Evidence map›Paper›PMID 40224704›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2025

Laboratory Profile of Lupus Anticoagulant Positive Cases and its Association with Clinical Presentation- Experience from a Tertiary Care Centre in Southern India.

Pranav Raghuram, Mithraa Devi Sekar, Lokeshwari Srinivasan, Prabhu Manivannan, Debdatta Basu, Rakhee Kar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pranav RaghuramDepartment of Pathology (Hematology Section), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006 India.
Mithraa Devi SekarDepartment of Pathology (Hematology Section), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006 India.
Lokeshwari SrinivasanDepartment of Pathology (Hematology Section), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006 India.
Prabhu ManivannanDepartment of Pathology (Hematology Section), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006 India.
Debdatta BasuDepartment of Pathology (Hematology Section), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006 India.
Rakhee KarDepartment of Pathology (Hematology Section), Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006 India.ORCID 0000-0001-6041-1512

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease with specific clinical features and the presence of antiphospholipid antibodies (aPL) like anti-beta2 glycoprotein 1 (anti-β2gp1), anti-cardiolipin antibody (aCL), and/or lupus anticoagulant (LA). The purpose of this study was to evaluate the laboratory profile of LA-positive cases and study its association with various clinical presentations. In this ambispective analytical study over 20 months, LA-positive cases (

Indexed as

aCLAntiphospholipid antibodiesDilute Russell’s viper venom timeDual LA positiveLupus anticoagulantThrombosis

Identifiers

PMID40224704
PMCPMC11992268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.